Since there was no significant decrease in blood pressure and no change in eGFR during this period, this weight loss was considered to be a change in fat mass rather than due to dehydration
When appetite decreases sharply, many patients accidentally eat less protein, triggering weakness and mental fog
Some people may experience mild redness, swelling, or discomfort at the injection site
Periodic Limb movement Disorder [Internet]
Clinical trials show patients on Semaglutide lose an average of 1517% of body weight, while Tirzepatide patients have seen up to 2225% weight loss
Dose adjustment considerations : In some cases, delaying dose escalation or temporarily reverting to a previously tolerated dose may be necessary to improve tolerability while maintaining therapeutic benefit